Jacob Ma-Weaver
CIK 1922140 · last filed 2024-08-30
Jacob Ma-Weaver is a corporate insider who has filed 12 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for ABIO, was dated Aug 30, 2024. Across all open-market trades the lifetime net is +$4.1M, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
12
$4.08M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Oruka Therapeutics, Inc. (ABIO) Delisted | Director | 6,580,904 | $28.80 | $189.53M | $2.20M | 11 | 2024-08-30 |
| Lite Strategy, Inc. (MEIP) Delisted | 10%+ Owner | 406,400 | $3.20 | $1.30M | $1.88M | 1 | 2023-09-22 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-30 | Oruka Therapeutics, Inc. (ABIO) Delisted | Other (J) | — | $0 | EDGAR |
| 2024-01-31 | Oruka Therapeutics, Inc. (ABIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-09-22 | Lite Strategy, Inc. (MEIP) Delisted | Buy (P) | +307,200 | $1.88M | EDGAR |
| 2022-12-19 | Oruka Therapeutics, Inc. (ABIO) Delisted | Mixed | +2,840,000 | $7.10M | EDGAR |
| 2022-06-21 | Oruka Therapeutics, Inc. (ABIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-25 | Oruka Therapeutics, Inc. (ABIO) Delisted | Buy (P) | +170,524 | $394.8K | EDGAR |
| 2022-05-20 | Oruka Therapeutics, Inc. (ABIO) Delisted | Buy (P) | +26,146 | $60.3K | EDGAR |
| 2022-05-09 | Oruka Therapeutics, Inc. (ABIO) Delisted | Buy (P) | +248,244 | $565.1K | EDGAR |
| 2022-05-02 | Oruka Therapeutics, Inc. (ABIO) Delisted | Buy (P) | +67,228 | $155.5K | EDGAR |
| 2022-04-27 | Oruka Therapeutics, Inc. (ABIO) Delisted | Mixed | +27,502 | $63.0K | EDGAR |